Table of Contents
ISRN Rheumatology
Volume 2011 (2011), Article ID 505171, 4 pages
http://dx.doi.org/10.5402/2011/505171
Clinical Study

The Performance of Quantiferon TB Gold In-Tube as a Screening Tool in Paediatric Rheumatology prior to Initiation of Infliximab: A Single Centre's Experience

1Academic Department of Paediatric and Adolescent Rheumatology, Great Ormond Street Hospital and Institute of Child Health, London WC1N 3JH, UK
2Rheumatology Department, Great Ormond Street Hospital NHS Trust, Great Ormond Street, London WC1N 3JH, UK

Received 16 April 2011; Accepted 27 May 2011

Academic Editors: M. Benucci and P. Voulgari

Copyright © 2011 Despoina Maritsi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. P. de León, E. Acevedo-Vásquez, A. Sánchez-Torres et al., “Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis,” Annals of the Rheumatic Diseases, vol. 64, no. 9, pp. 1360–1361, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Ferrara, M. Losi, R. D'Amico et al., “Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study,” The Lancet, vol. 367, no. 9519, pp. 1328–1334, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Saiman and P. Colson, “Targeted tuberculin skin testing and treatment of latent tuberculosis infection in children and adolescents,” Pediatrics, vol. 114, no. 4, pp. 1175–1201, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Brock, M. Ruhwald, B. Lundgren, H. Westh, L. R. Mathiesen, and P. Ravn, “Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-γ test,” Respiratory Research, vol. 7, article 56, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Pratt, K. Nicholl, and L. Kay, “Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-α agents: the Newcastle (UK) experience,” Rheumatology, vol. 46, no. 6, pp. 1035–1036, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Assante, M. Bocchino, M. Alessio, R. Ambrosi, A. Sanduzzi, and A. Guarino, “Performance of IFN-gamma release assays for detection of tuberculosis infection in JIA children on biological therapy,” Pediatric Rheumatology, vol. 6, supplement 1, p. 60, 2008. View at Publisher · View at Google Scholar
  7. T. Haustein, D. A. Ridout, J. C. Hartley et al., “The likelihood of an indeterminate test result from a whole-blood interferon-γ release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status,” Pediatric Infectious Disease Journal, vol. 28, no. 8, pp. 669–673, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. R. S. Wallis, M. S. Broder, J. Y. Wong, M. E. Hanson, and D. O. Beenhouwer, “Granulomatous infectious diseases associated with tumour necrosis factor anatagonists: correction,” Clinical Infectious Diseases, vol. 38, no. 9, pp. 1261–1265, 2004. View at Google Scholar